-
Deep-ER: Deep Learning ECCENTRIC Reconstruction for fast high-resolution neurometabolic imaging
Authors:
Paul Weiser,
Georg Langs,
Wolfgang Bogner,
Stanislav Motyka,
Bernhard Strasser,
Polina Golland,
Nalini Singh,
Jorg Dietrich,
Erik Uhlmann,
Tracy Batchelor,
Daniel Cahill,
Malte Hoffmann,
Antoine Klauser,
Ovidiu C. Andronesi
Abstract:
Introduction: Altered neurometabolism is an important pathological mechanism in many neurological diseases and brain cancer, which can be mapped non-invasively by Magnetic Resonance Spectroscopic Imaging (MRSI). Advanced MRSI using non-cartesian compressed-sense acquisition enables fast high-resolution metabolic imaging but has lengthy reconstruction times that limits throughput and needs expert u…
▽ More
Introduction: Altered neurometabolism is an important pathological mechanism in many neurological diseases and brain cancer, which can be mapped non-invasively by Magnetic Resonance Spectroscopic Imaging (MRSI). Advanced MRSI using non-cartesian compressed-sense acquisition enables fast high-resolution metabolic imaging but has lengthy reconstruction times that limits throughput and needs expert user interaction. Here, we present a robust and efficient Deep Learning reconstruction to obtain high-quality metabolic maps.
Methods: Fast high-resolution whole-brain metabolic imaging was performed at 3.4 mm$^3$ isotropic resolution with acquisition times between 4:11-9:21 min:s using ECCENTRIC pulse sequence on a 7T MRI scanner. Data were acquired in a high-resolution phantom and 27 human participants, including 22 healthy volunteers and 5 glioma patients. A deep neural network using recurring interlaced convolutional layers with joint dual-space feature representation was developed for deep learning ECCENTRIC reconstruction (Deep-ER). 21 subjects were used for training and 6 subjects for testing. Deep-ER performance was compared to conventional iterative Total Generalized Variation reconstruction using image and spectral quality metrics.
Results: Deep-ER demonstrated 600-fold faster reconstruction than conventional methods, providing improved spatial-spectral quality and metabolite quantification with 12%-45% (P<0.05) higher signal-to-noise and 8%-50% (P<0.05) smaller Cramer-Rao lower bounds. Metabolic images clearly visualize glioma tumor heterogeneity and boundary.
Conclusion: Deep-ER provides efficient and robust reconstruction for sparse-sampled MRSI. The accelerated acquisition-reconstruction MRSI is compatible with high-throughput imaging workflow. It is expected that such improved performance will facilitate basic and clinical MRSI applications.
△ Less
Submitted 26 September, 2024;
originally announced September 2024.
-
Model predictive control for the prescription of antithyroid agents
Authors:
Maylin Menzel,
Tobias M. Wolff,
Johannes W. Dietrich,
Matthias A. Müller
Abstract:
Although hyperthyroidism is a common disease, the pharmaceutical therapy is based on a trial-and-error approach. We extend a mathematical model of the pituitary-thyroid feedback loop such that the intake of one antithyroid agent, namely methimazole (MMI), can be considered and use a model predictive control (MPC) scheme to determine suitable dosages.
Although hyperthyroidism is a common disease, the pharmaceutical therapy is based on a trial-and-error approach. We extend a mathematical model of the pituitary-thyroid feedback loop such that the intake of one antithyroid agent, namely methimazole (MMI), can be considered and use a model predictive control (MPC) scheme to determine suitable dosages.
△ Less
Submitted 31 July, 2023;
originally announced July 2023.
-
Modeling and Predictive Control for the Treatment of Hyperthyroidism
Authors:
Tobias M. Wolff,
Maylin Menzel,
Johannes W. Dietrich,
Matthias A. Müller
Abstract:
In this work, we propose an approach to determine the dosages of antithyroid agents to treat hyperthyroid patients. Instead of relying on a trial-and-error approach as it is commonly done in clinical practice, we suggest to determine the dosages by means of a model predictive control (MPC) scheme. To this end, we first extend a mathematical model of the pituitary-thyroid feedback loop such that th…
▽ More
In this work, we propose an approach to determine the dosages of antithyroid agents to treat hyperthyroid patients. Instead of relying on a trial-and-error approach as it is commonly done in clinical practice, we suggest to determine the dosages by means of a model predictive control (MPC) scheme. To this end, we first extend a mathematical model of the pituitary-thyroid feedback loop such that the intake of methimazole, a common antithyroid agent, can be considered. Second, based on the extended model, we develop an MPC scheme to determine suitable dosages. In numerical simulations, we consider scenarios in which (i) patients are affected by Graves' disease and take the medication orally and (ii) patients suffering from a life-threatening thyrotoxicosis, in which the medication is usually given intravenously. Our conceptual study suggests that determining the medication dosages by means of an MPC scheme could be a promising alternative to the currently applied trial-and-error approach.
△ Less
Submitted 16 January, 2025; v1 submitted 20 December, 2022;
originally announced December 2022.
